HCG 2500 IU

Dragon Pharma HCG 2500 IU

HCG 2500 IU by Dragon Pharma is a lyophilized gonadotropin product studied in protocols related to post-cycle support, testicular function, and fertility-related applications. Human Chorionic Gonadotropin is widely known in both clinical and performance-focused settings because of its ability to mimic luteinizing hormone activity at the testicular level.

Among athletes and bodybuilders, HCG is commonly discussed in post-cycle planning and hormonal support protocols where maintaining testicular responsiveness is an important consideration. For users looking to buy HCG 2500 IU by Dragon Pharma, product quality, correct storage, and reliable sourcing remain key factors.

HCG 2500 IU Composition

Human Chorionic Gonadotropin (HCG) is a glycoprotein hormone composed of alpha and beta subunits. It is biologically active through interaction with the LH/CG receptor, where it can mimic the action of endogenous luteinizing hormone.

This LH-like activity is why HCG is commonly studied in male hormonal support protocols, fertility-related applications, and post-cycle settings where testicular stimulation is relevant.

Bodybuilding and Hormonal Support

In performance-focused settings, HCG is most often researched for its role in supporting testicular function during or after periods of hormonal suppression. It is frequently discussed in connection with recovery-oriented hormone protocols and structured post-cycle planning.

• Testicular function support: studied for LH-like stimulation at the testicular level
• Post-cycle use: commonly discussed in structured recovery protocols
• Fertility-related support: often researched where intratesticular activity is relevant
• Hormonal transition support: frequently mentioned during periods of endocrine recovery
• Cycle planning relevance: widely discussed by users who prioritize responsible hormone management

For more background on HCG in male hormonal therapy, you can refer to this PubMed study on HCG therapy in men.

Research Background

HCG has been studied in a range of therapeutic and endocrine settings, including male hypogonadism, fertility-related treatment, pubertal development, and testicular stimulation protocols. In performance-focused discussions, its main relevance is its ability to provide LH-like signaling when endogenous LH activity is reduced.

This profile makes HCG one of the most recognized compounds in post-cycle and reproductive hormone-related discussions.

Dosage (Men)

Note: HCG is intended for research purposes only. The following reflects common protocol patterns and your provided context rather than medical advice.

HCG is commonly researched through subcutaneous or intramuscular protocols. Common examples include:

• During-Cycle Support: 250-500 IU twice weekly
• Pre-PCT Protocol: 500-1000 IU every other day for a short protocol period
• Higher-Range Protocols: sometimes discussed in fertility-related settings under medical supervision

The 2500 IU vial is commonly reconstituted with 2 mL of bacteriostatic water, creating a concentration of 1250 IU/mL. At that concentration, a 250 IU dose equals 0.2 mL, or 20 units on a U-100 insulin syringe. A 500 IU dose equals 0.4 mL, and a 1000 IU dose equals 0.8 mL.

Dosage (Women)

Women may encounter HCG in medically supervised fertility protocols, but in performance-focused contexts it is generally not discussed as a routine compound. Any use in women should remain under direct medical guidance due to its hormonal effects.

Active Life

HCG has a relatively long biologic activity profile compared with many peptides, which is why intermittent dosing is commonly discussed rather than daily use in standard hormone-support protocols.

HCG Side Effects

HCG is generally discussed as well tolerated when used conservatively, though side effects may include fluid retention, headache, mood changes, acne, injection-site irritation, or estrogen-related effects depending on the overall hormone environment and protocol design.

Because HCG may increase downstream testosterone and estrogen activity, users often pay close attention to timing, duration, and total protocol structure.

HCG Contraindications/Precautionary Measures

HCG should not be used by women who are pregnant or breastfeeding. Individuals with hormone-sensitive conditions, serious endocrine disorders, cardiac disease, or significant fluid-retention issues should use caution. Because prolonged use may reduce responsiveness over time, protocol duration is often kept limited in research discussions. Proper sterile handling and storage should always be followed. Keep out of reach of children.

Overdosage

Excessive use may increase the likelihood of headache, fluid retention, hormonal side effects, gynecomastia risk, or testicular discomfort. Because HCG has a longer activity profile than many peptides, unwanted effects may persist longer after overuse.

HCG Stack/Cycle

HCG is often researched as part of broader post-cycle and hormone-support protocols. Common combinations include:

• Nolvadex (Tamoxifen Citrate) – frequently discussed in structured post-cycle protocols
• Clomid (Clomiphene Citrate) – commonly researched in hormone-recovery and SERM-based support plans
• HCG 5000 IU – sometimes considered when higher-volume or longer-duration protocols are being compared

These combinations are typically explored by users focused on post-cycle planning, hormone support, and preserving long-term endocrine health.

Package Presentation

Dragon Pharma presents HCG in a sterile 2 mL vial containing 2500 IU of lyophilized powder. The freeze-dried format helps preserve stability before reconstitution and supports accurate dose preparation.

Storage

Store the lyophilized vial in a cool, dry place away from direct light and moisture, ideally at 2-8°C. After reconstitution with bacteriostatic water, keep refrigerated and use within 4-6 weeks for best stability. Do not freeze.

HCG Referrers

This product is intended for laboratory research and analytical purposes only. Not for human consumption. Always verify the legality of this compound in your jurisdiction before purchase.

Third-Party Lab Test Results

Dragon Pharma is committed to transparency and quality. Below are the latest third-party lab test results for HCG 2500 IU, verifying purity and accurate dosing.

2023-09-28

View Result

2976 IU

Lab test conducted: 2023-09-28 | Result: 2976 IU (119% of labeled dose)

HCG 2500 IU Frequently Asked Questions